IRIS
LANINI, Simone
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.445
NA - Nord America 1.969
EU - Europa 759
SA - Sud America 589
Continente sconosciuto - Info sul continente non disponibili 342
AF - Africa 36
OC - Oceania 4
Totale 6.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.860
SG - Singapore 1.093
BR - Brasile 479
CN - Cina 380
HK - Hong Kong 345
IT - Italia 269
VN - Vietnam 214
BD - Bangladesh 162
RU - Federazione Russa 111
FR - Francia 99
KR - Corea 80
GB - Regno Unito 57
CA - Canada 53
NL - Olanda 42
AR - Argentina 38
DE - Germania 36
IN - India 31
ID - Indonesia 29
MX - Messico 24
EC - Ecuador 21
PL - Polonia 20
SE - Svezia 18
IQ - Iraq 17
AT - Austria 16
ES - Italia 16
TR - Turchia 15
CO - Colombia 14
FI - Finlandia 12
IE - Irlanda 10
JP - Giappone 10
VE - Venezuela 10
ZA - Sudafrica 10
PK - Pakistan 9
UA - Ucraina 9
PY - Paraguay 8
CL - Cile 7
CR - Costa Rica 7
JM - Giamaica 7
SA - Arabia Saudita 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
KZ - Kazakistan 6
MY - Malesia 6
RO - Romania 6
CH - Svizzera 5
BE - Belgio 4
EG - Egitto 4
GE - Georgia 4
KE - Kenya 4
MA - Marocco 4
PE - Perù 4
UZ - Uzbekistan 4
AU - Australia 3
AZ - Azerbaigian 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
GR - Grecia 3
HN - Honduras 3
IL - Israele 3
LT - Lituania 3
LV - Lettonia 3
NP - Nepal 3
RS - Serbia 3
TN - Tunisia 3
BF - Burkina Faso 2
BY - Bielorussia 2
GT - Guatemala 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
PA - Panama 2
PH - Filippine 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MR - Mauritania 1
MT - Malta 1
NI - Nicaragua 1
Totale 5.796
Salva come PNG Salva come JPEG
Città #
Singapore 502
Hong Kong 341
Ashburn 251
Council Bluffs 242
San Jose 164
Beijing 140
Boardman 124
Los Angeles 92
Dallas 88
Lauterbourg 88
Hefei 79
Seoul 79
Santa Clara 75
Ho Chi Minh City 71
Hanoi 49
New York 39
Buffalo 38
Redondo Beach 38
The Dalles 34
São Paulo 33
Phoenix 28
Milan 26
Atlanta 23
Montreal 20
Warsaw 20
Rome 19
Amsterdam 18
Orem 18
Stockholm 16
Brooklyn 15
Chennai 13
Rio de Janeiro 13
Chicago 12
Udine 12
Brasília 11
San Francisco 11
Dublin 10
Frankfurt am Main 10
Guangzhou 10
Guayaquil 10
Houston 10
Mexico City 10
Naples 10
Tokyo 10
Toronto 10
Da Nang 9
Denver 9
Haiphong 9
Vienna 9
Boston 8
Helsinki 8
Wuhan 8
Bologna 7
Campinas 7
Jakarta 7
Newark 7
Nuremberg 7
Pelotas 7
Porto Alegre 7
Quito 7
San José 7
Tombolo 7
Baghdad 6
Bari 6
Bogotá 6
Curitiba 6
Dhaka 6
Düsseldorf 6
Florence 6
Johannesburg 6
London 6
Manchester 6
Montevideo 6
Mumbai 6
Shenzhen 6
Asunción 5
Belford Roxo 5
Belo Horizonte 5
Biên Hòa 5
Cuiabá 5
Feira de Santana 5
Figino 5
Ha Long 5
Kingston 5
Las Vegas 5
Milwaukee 5
Osasco 5
Ribeirão Preto 5
São José dos Campos 5
Thái Bình 5
Ankara 4
Belluno 4
Buenos Aires 4
Dong Ket 4
Goiânia 4
Itaquaquecetuba 4
Joinville 4
Maceió 4
Madrid 4
Phủ Lý 4
Totale 3.255
Salva come PNG Salva come JPEG
Nome #
Comparison of SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples from Patients Infected with Omicron Variant 379
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 148
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study 137
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 116
Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: Outbreak investigation and infection outcome 109
Ebola virus disease complicated with viral interstitial pneumonia: A case report 99
Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study) 97
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 93
Prolonged low-dose methylprednisolone in patients with severe COVID-19 pneumonia 93
Comparative Analysis of Early COVID-19 Treatment Efficacy in a Multicentric Regional Cohort in Italy: Emulation of a Series of Target Trials 92
Safety and Pharmacokinetic Profiles of Subcutaneous Administration of Beta-Lactams: A Systematic Review 91
Effectiveness and Tolerability of DOR/3TC/TDF in Experienced People with HIV Switching from RPV/FTC/TDF: A Retrospective, Single Center Cohort Study 91
Chikungunya Outbreak in the Republic of the Congo, 2019—Epidemiological, Virological and Entomological Findings of a South-North Multidisciplinary Taskforce Investigation 81
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 80
The middle east respiratory syndrome coronavirus – a continuing risk to global health security 79
Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient 76
Risk of infection in patients with lymphoma receiving rituximab: Systematic review and meta-analysis 76
Blood kinetics of Ebola virus in survivors and nonsurvivors 75
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997–2022: Data From the Icona Cohort 74
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 73
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen 73
Clinical experience with use of oral Tecovirimat or Intravenous Cidofovir for the treatment of Monkeypox in an Italian reference hospital: USE OF ANTIVIRALS FOR MONKEYPOX IN AN ITALIAN HOSPITAL 72
COVID-19 disease - Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study 71
Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study 70
Characteristics and Outcomes of COVID-19-Related Hospitalization among PLWH 68
Benefits of steroid therapy in COVID-19 patients with different PaO2/FiO2 ratio at admission 68
Appropriateness of surgical antimicrobial prophylaxis in the Latium Region of Italy, 2008: A multicenter study 66
Case definition for Ebola and Marburg haemorrhagic fevers: a complex challenge for epidemiologists and clinicians 65
Detection of recombinant breakpoint in the genome of human enterovirus E11 strain associated with a fatal nosocomial outbreak 65
Relationship between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study 64
Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects 63
A large epidemic of hepatitis B in Serbia: An integrated model for outbreak investigations in healthcare settings 63
A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017 63
Risk Awareness as a Key Determinant of Early Vaccine Uptake in the Mpox Vaccination Campaign in an Italian Region: A Cross-Sectional Analysis 62
Ebola: Missed opportunities for Europe-Africa research 62
Epidemiology of HEV in the mediterranean basin: 10-year prevalence in Italy 60
SARS-CoV-2 mRNA Vaccine Response in People Living with HIV According to CD4 Count and CD4/CD8 Ratio 60
Noninvasive positive-pressure ventilation 59
Patient to patient transmission of hepatitis B virus: A systematic review of reports on outbreaks between 1992 and 2007 59
Temporal intra-host variability of mpox virus genomes in multiple body tissues 59
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa? 58
Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results 58
Viral hemorrhagic fevers: Advancing the level of treatment 58
Criteria for discharge of patients with Ebola virus diseases in high-income countries 57
Liver transplant recipients and prioritization of anti-HCV therapy: An Italian cohort analysis 57
Hepatitis C: global epidemiology and strategies for control 57
Author's reply: measles on a cruise ship--links with the outbreak in the Philippines 57
Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19 56
Pooled analysis of the MANTICO2 and MONET randomized controlled trials comparing drug efficacy for early treatment of COVID-19 during Omicron waves 56
Hospital cluster of HBV infection: Molecular evidence of patient-to-patient transmission through lancing device 56
Switching to bictegravir/emtricitabine/tenofovir alafenamide from efavirenz/emtricitabine/tenofovir disoproxil in virologically suppressed people with HIV: findings from a non-randomized clinical trial (EBONY study) 55
Incidence of carbapenem-resistant gram negatives in Italian transplant recipients: A nationwide surveillance study 55
Local transmission of chikungunya in Rome and the lazio region, Italy 54
Non-randomised Ebola trials-lessons for optimal outbreak research 54
High-level tolerance to triclosan may play a role in Pseudomonas aeruginosa antibiotic resistance in immunocompromised hosts: Evidence from outbreak investigation 53
Epidemiology of viral hepatitis in men who have sex with men in Mediterranean Europe: a region-wide sero-surveillance in Rome (Italy) 53
Incidence of SARS-CoV-2 Infection and Related Mortality by Education Level during Three Phases of the 2020 Pandemic: A Population-Based Cohort Study in Rome 53
Immunological signature in human cases of monkeypox infection in 2022 outbreak: an observational study 53
Pulmonary involvement during the Ebola virus disease 53
Analysis of Diagnostic Findings from the European Mobile Laboratory in Guéckédou, Guinea, March 2014 Through March 2015 52
Recovery of metabolic impairment in patients who cleared chronic hepatitis C infection after direct-acting antiviral therapy 52
Cefepime-Taniborbactam in Complicated Urinary Tract Infection 52
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIV 51
Burden of advanced HIV disease among antiretroviral therapy-experienced persons with HIV in Italy over the past 20 years 51
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries 50
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count 50
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in PLWH 50
Authors reply: measles on the cruise ship: links with virus spreading into an emergency department in Southern Italy 50
SELP Asp603Asn and severe thrombosis in COVID-19 males 49
Infections in patients taking Rituximab for hematologic malignancies: Two-year cohort study 49
Molecular epidemiology of a Pseudomonas aeruginosa hospital outbreak driven by a contaminated disinfectant-soap dispenser 48
The added value of long-lasting preparedness for the management of a patient with Ebola 48
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection 48
Influenza A (H1N1) in Rome, Italy in family: Three case reports 48
Is hepatitis C virus eradication around the corner only 25 years after its discovery? 48
The surveillance of chikungunya virus in a temperate climate: Challenges and possible solutions from the experience of Lazio Region, Italy 47
Inflammatory and humoral immune response during ebola virus infection in survivor and fatal cases occurred in sierra leone during the 2014–2016 outbreak in west Africa 46
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV 46
The possible effect of sociobehavioral factors and public health actions on the mpox epidemic slowdown 46
Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach 45
Short-term economic impact of the Zika virus outbreak 45
Hepatitis C virus treatment revolution: Need for close monitoring 44
Effect of tecovirimat on healing time and viral clearance by emulation of a target trial in patients hospitalized for mpox 44
Measles cases during ebola outbreak, West Africa, 2013–2106 43
SARS-CoV-2 Early Screening at the Point of Entry: Travelers From Bangladesh to Italy–July 2020 43
Reply to Reisler et al 43
Risk management of febrile respiratory illness in emergency departments 43
Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents 43
RE: Measles on the cruise ship: Links with virus spreading into an emergency department in southern Italy 42
Frequency of detection of upper respiratory tract viruses in patients tested for pandemic H1N1/09 viral infection 41
Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 40
Hiv/hcv co-infection: Putting the pieces of the puzzle together 37
Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? 36
HIV Oral Pre-exposure Prophylaxis Effectiveness, Adherence, and Discontinuation in an Italian Multicentric Access Program: ItaPrEP Study 34
CT changes in a randomized trial comparing early therapies in an outpatient population at high risk of severe COVID19 disease 29
Mpox virus in human breastmilk and tecovirimat pharmacokinetics: implications for postnatal transmission 7
Totale 6.144
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.321
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.321
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 1 2 1
2022/20232 1 0 0 0 0 1 0 0 0 0 0 0
2023/20247 0 0 0 0 1 0 0 3 0 1 0 2
2024/20251.893 1 464 206 30 45 66 61 64 111 67 351 427
2025/20263.376 144 283 525 483 398 217 285 104 102 226 408 201
2026/2027852 475 171 206 0 0 0 0 0 0 0 0 0
Totale 6.144